BPC 157 Prosperxlabs Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what The Blacklisting of Peptides Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law